
AngioInsight Adds Shlomi Nachman to Board, Raises Series A
Funding accelerates advancement of AngioAI+, the company’s investigational AI-based platform for diagnosing CAD and CMD. AngioInsight, a leader in AI-powered cardiovascular diagnostics, announced the appointment of Shlomi
